These hypotheses provide considerable insight into the prognostic role of MDM2 in HPV+ HNSCC patients, however, further studies are needed to accurately understand the association between HPV status, MDM2 expression and patients’ outcomes. The gene discussed is MDM2; the disease is head and neck squamous cell carcinoma.